This procedure is designed to treat acquired nasolacrimal duct obstruction in adults. The obstruction causes epiphora, recurrent infections of the lacrimal sac (dacryocystitis), and purulent discharge. In DCR, a new drainage pathway is created between the lacrimal sac and the nasal cavity to allow tears to drain directly into the nose.
Before procedure
The location and severity of the obstruction are confirmed, if necessary, using imaging methods such as dacryocystography. As with other surgeries, discontinuing blood-thinning medications is essential to reduce the risk of bleeding during the procedure.
After procedure
Gentle nasal irrigation with saline solution is important for clearing the passage and preventing crust formation. Forceful blowing or sneezing with the mouth closed should be avoided. The use of intranasal steroid spray to reduce internal nasal swelling is essential if prescribed by the ophthalmologist.
Complication and alarm signs
Bleeding from the nose or the inner area of the eye, localized or widespread infection, formation of scar tissue within the new pathway and its closure (recurrence of obstruction) are complications of this surgery. If a temporary stent tube is placed in the pathway, displacement or expulsion of the tube may occur.